119 related articles for article (PubMed ID: 7507170)
1. Defining the requirements for an antibody epitope on influenza virus neuraminidase: how tolerant are protein epitopes?
Nuss JM; Air GM
J Mol Biol; 1994 Jan; 235(2):747-59. PubMed ID: 7507170
[TBL] [Abstract][Full Text] [Related]
2. Identification of critical contact residues in the NC41 epitope of a subtype N9 influenza virus neuraminidase.
Nuss JM; Whitaker PB; Air GM
Proteins; 1993 Feb; 15(2):121-32. PubMed ID: 7680132
[TBL] [Abstract][Full Text] [Related]
3. Critical interactions in binding antibody NC41 to influenza N9 neuraminidase: amino acid contacts on the antibody heavy chain.
Pruett PS; Air GM
Biochemistry; 1998 Jul; 37(30):10660-70. PubMed ID: 9692956
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of antigenic variation in an individual epitope on influenza virus N9 neuraminidase.
Air GM; Laver WG; Webster RG
J Virol; 1990 Dec; 64(12):5797-803. PubMed ID: 1700825
[TBL] [Abstract][Full Text] [Related]
5. Three-dimensional structure of neuraminidase of subtype N9 from an avian influenza virus.
Baker AT; Varghese JN; Laver WG; Air GM; Colman PM
Proteins; 1987; 2(2):111-7. PubMed ID: 3447170
[TBL] [Abstract][Full Text] [Related]
6. Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex.
Tulip WR; Varghese JN; Laver WG; Webster RG; Colman PM
J Mol Biol; 1992 Sep; 227(1):122-48. PubMed ID: 1381757
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional structure of influenza A N9 neuraminidase and its complex with the inhibitor 2-deoxy 2,3-dehydro-N-acetyl neuraminic acid.
Bossart-Whitaker P; Carson M; Babu YS; Smith CD; Laver WG; Air GM
J Mol Biol; 1993 Aug; 232(4):1069-83. PubMed ID: 8371267
[TBL] [Abstract][Full Text] [Related]
8. Identification of overlapping class I and class II H-2d-restricted T cell determinants of influenza virus N1 neuraminidase that require infectious virus for presentation.
Wysocka M; Eisenlohr LC; Otvos L; Horowitz D; Yewdell JW; Bennink JR; Hackett CJ
Virology; 1994 May; 201(1):86-94. PubMed ID: 7513927
[TBL] [Abstract][Full Text] [Related]
9. Interaction between a 1998 human influenza virus N2 neuraminidase and monoclonal antibody Mem5.
Lee JT; Air GM
Virology; 2006 Feb; 345(2):424-33. PubMed ID: 16297424
[TBL] [Abstract][Full Text] [Related]
10. Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98).
Gulati U; Hwang CC; Venkatramani L; Gulati S; Stray SJ; Lee JT; Laver WG; Bochkarev A; Zlotnick A; Air GM
J Virol; 2002 Dec; 76(23):12274-80. PubMed ID: 12414967
[TBL] [Abstract][Full Text] [Related]
11. The neuraminidase of influenza virus.
Air GM; Laver WG
Proteins; 1989; 6(4):341-56. PubMed ID: 2482974
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the binding of the Fab fragment of monoclonal antibody NC10 to influenza virus N9 neuraminidase from tern and whale using the BIAcore biosensor: effect of immobilization level and flow rate on kinetic analysis.
Kortt AA; Nice E; Gruen LC
Anal Biochem; 1999 Aug; 273(1):133-41. PubMed ID: 10452809
[TBL] [Abstract][Full Text] [Related]
13. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
[TBL] [Abstract][Full Text] [Related]
14. Contacts between influenza virus N9 neuraminidase and monoclonal antibody NC10.
Lee JT; Air GM
Virology; 2002 Sep; 300(2):255-68. PubMed ID: 12350356
[TBL] [Abstract][Full Text] [Related]
15. Antigenicity of the N8 influenza A virus neuraminidase: existence of an epitope at the subunit interface of the neuraminidase.
Saito T; Taylor G; Laver WG; Kawaoka Y; Webster RG
J Virol; 1994 Mar; 68(3):1790-6. PubMed ID: 7509002
[TBL] [Abstract][Full Text] [Related]
16. Chimeric influenza viruses incorporating epitopes of outer membrane protein F as a vaccine against pulmonary infection with Pseudomonas aeruginosa.
Gilleland HE; Gilleland LB; Staczek J; Harty RN; Garcia-Sastre A; Engelhardt OG; Palese P
Behring Inst Mitt; 1997 Feb; (98):291-301. PubMed ID: 9382753
[TBL] [Abstract][Full Text] [Related]
17. N9 neuraminidase complexes with antibodies NC41 and NC10: empirical free energy calculations capture specificity trends observed with mutant binding data.
Tulip WR; Harley VR; Webster RG; Novotny J
Biochemistry; 1994 Jul; 33(26):7986-97. PubMed ID: 7517697
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of a peptide complex of anti-influenza peptide antibody Fab 26/9. Comparison of two different antibodies bound to the same peptide antigen.
Churchill ME; Stura EA; Pinilla C; Appel JR; Houghten RA; Kono DH; Balderas RS; Fieser GG; Schulze-Gahmen U; Wilson IA
J Mol Biol; 1994 Aug; 241(4):534-56. PubMed ID: 7520084
[TBL] [Abstract][Full Text] [Related]
19. A monoclonal antibody targeting a highly conserved epitope in influenza B neuraminidase provides protection against drug resistant strains.
Doyle TM; Li C; Bucher DJ; Hashem AM; Van Domselaar G; Wang J; Farnsworth A; She YM; Cyr T; He R; Brown EG; Hurt AC; Li X
Biochem Biophys Res Commun; 2013 Nov; 441(1):226-9. PubMed ID: 24140051
[TBL] [Abstract][Full Text] [Related]
20. Structural details of HIV-1 recognition by the broadly neutralizing monoclonal antibody 2F5: epitope conformation, antigen-recognition loop mobility, and anion-binding site.
Julien JP; Bryson S; Nieva JL; Pai EF
J Mol Biol; 2008 Dec; 384(2):377-92. PubMed ID: 18824005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
